Natco Pharma hits a 52-week high after firm reports Q4 results; know what Anil Singhvi suggests for mid-cap stock

Natco Pharma Share Price: Natco Pharma hit a 52-week high of Rs 1,108.95 on BSE on Tuesday after the mid-cap firm reported strong set of fourth-quarter results a day ago.

After the company reported its Q4 results, Zee Business managing editor Anil Singhvi gave a 'buy' call on the stock with a target price and stop loss.

After closing at Rs 1,029.20 in the previous session, the Natco Pharma stock soared by 7.75 per cent to hit a 52-week high on Tuesday.

Natco Pharma shares started the trading session at Rs 1,108.95 each on Tuesday, which turned out to be its 52-week high, closed trading up by 0.30 per cent, or Rs 3.10, at Rs 1,032.30 on Tuesday.

The stock's day's low on Tuesday was Rs 1,029.00. 

Natco Pharma Q4 YoY consolidated results

Natco Pharma reported a 40 per cent rise in its profit after tax (PAT) to Rs 386 core in the fourth quarter from Rs 276 crore Year-on-Year (YoY).

The pharma company's revenue from operations was up by 19 per cent to Rs 1,068 crore in the quarter under review from Rs 898 crore in the same quarter last fiscal.

Its EBITDA soared by 46 per cent to Rs 496.7 crore in Q4 from Rs 339.70 crore in the same quarter last year. 

The mid-cap company's margin also rose to 46.5 per cent in the fourth quarter compared to 37.83 per cent in the corresponding period last fiscal.  

Anil Singhvi's view on Torrent Pharma

Singhvi gave a 'buy' call on Natco Pharma with a stop loss at Rs 1,015 and targets of Rs 1,040, Rs 1,054 and Rs 1,070.

He says that the company's operational performance is very strong and it has recorded its highest-ever revenue and profit for the whole year.